P399: C-Reactive Protein Values After Surgery for Inflammatory Bowel Disease: Is It Still A Good Marker For Intra-Abdominal Complication? A Retrospective Cohort Study of 347 procedures.ECCO'22Year: 2022
Authors: Gaspard, B.(1);Alexandre, C.(1);thibault, V.(1);Lauren, O.(2);Clotilde, D.(1);Najim, C.(1);yann, P.(1);Lefevre, J.(1);
(1)APHP St. Antoine Hospital, Department of General and Digestive Surgery, Paris, France;(2)St Vincent's University Hospital, Department of Colorectal Surgery, Dublin, Ireland;Saint-Antoine IBD Network
P400: Evolution of clinical and pharmacological parameters after switching from intra-venous to subcutaneous infliximab in patients with inflammatory bowel disease: the REMSWITCH studyECCO'22Year: 2022
Authors: Buisson, A.(1);Nachury, M.(2);Reymond, M.(1);Yzet, C.(3);Wils, P.(2);Payen, L.(1);Manlay, L.(1);Pereira, B.(4);Fumery, M.(3);
(1)University Hospital Estaing, Department of Gastroenterology- IBD Unit, Clermont-Ferrand, France;(2)CHRU Lille, IBD Unit, Lille, France;(3)CHU Amiens, IBD Unit, Amiens, France;(4)CHU Clermont-Ferrand, DRCI Biostatistics Unit, Clermont-Ferrand, France;
P401: Tofacitinib tissue exposure correlates with endoscopic outcomeECCO'22Year: 2022
Authors: Verstockt., B.(1,2);Alsoud, D.(2);van Oostrom, J.(3);Smith, J.(4);Stylli, J.(4);Singh, S.(4);van Gennep, S.(3);Rahimian, P.(4);Sabino, J.(1,2);Ferrante, M.(1,2);Singh, S.(4);D'Haens, G.(1);Vermeire, S.(1,2);
(1)University Hospitals Leuven, Dpt. Gastroenterology and Hepatology, Leuven, Belgium;(2)KU Leuven, Dpt. Chronic Diseases and Metabolism, Leuven, Belgium;(3)Amsterdam UMC, Dpt. Gastroenterology and Hepatology, Amsterdam, The Netherlands;(4)Progenity, Progenity, San Diego, United States;
P402: Incidence and outcomes of herpes zoster in the ozanimod phase 3 ulcerative colitis and relapsing multiple sclerosis clinical programECCO'22Year: 2022
Authors: Siegmund, B.(1);Melmed, G.Y.(2);Irving, P.M.(3);Pai, A.(4);Patel, A.(4);Sheffield, J.K.(4);Caldera, F.(5);Cree, B.A.C.(6);Dubinsky, M.C.(7);
(1)Charité – Universitätsmedizin Berlin, Gastroenterology- Infectiology and Rheumatology, Berlin, Germany;(2)Cedars-Sinai Medical Center, Gastroenterology, Los Angeles, United States;(3)Guy’s and St Thomas’ NHS Foundation Trust, Gastroenterology, London, United Kingdom;(4)Bristol Myers Squibb, Department of Immunology and Fibrosis Development, Princeton, United States;(5)University of Wisconsin-Madison School of Medicine and Public Health, Gastroenterology, Madison, United States;(6)University of California- San Francisco Medical Center, Neurology, San Francisco, United States;(7)Mount Sinai Kravis, Gastroenterology, New York, United States;
P403: The role of Organic Cation Transporter (OCTN)-1 in predicting individual response to therapy in Ulcerative Colitis: towards a personalized approach.ECCO'22Year: 2022
Authors: Puca, P.(1);Capobianco, I.(1);Petito, V.(1);Masi, L.(1);Fidaleo, M.(2);Del Chierico , F.(3);Palucci, I.(4);Lopetuso, L.R.(1);Laterza, L.(1);Settanni, C.R.(1);Parisio, L.(1);Bibbò, S.(1);Pugliese, D.(1);Armuzzi, A.(1);Pani, G.(5);Gasbarrini, A.(1);Scaldaferri, F.(1);
(1)Fondazione Policlinico Universitario A. Gemelli IRCCS, Department of Gastroenterology and Internal Medicine, Rome, Italy;(2)Università La Sapienza, Department of Biology and Biotechnologies @Charles Darwin@, Rome, Italy;(3)Children Hospital Bambino Gesù IRCCS, Unit of Human Microbiome, Rome, Italy;(4)Fondazione Policlinico Universitario A. Gemelli IRCCS, Department of Microbiology, Rome, Italy;(5)Catholic University of the Sacred Heart, Department of Translational Medicine, Rome, Italy;
P404: Underrepresentation of minorities and lack of race reporting in ulcerative colitis drug development clinical trialsECCO'22Year: 2022
Authors: Sedano, R.(1,2);Hogan, M.(3);McDonald, C.(4);Aswani-Omprakash, T.(5);Ma, C.(2,6);Jairath, V.(2,7);
(1)Western University, Division of Gastroenterology- Department of Medicine, London, Canada;(2)Alimentiv Inc, Gastroenterology, London, Canada;(3)Alimentiv Inc, n/a, London, Canada;(4)Lawson Health Research Institute- Western University, n/a, London, Canada;(5)Patient Advocate, n/a, New York, United States;(6)University of Calgary, Division of Gastroenterology & Hepatology- Departments of Medicine and Community Health Sciences, Calgary, Canada;(7)Western University, Division of Gastroenterology- Department of Medicine / Department of Epidemiology and Biostatistics, London, Canada;
P405: Primary non-response and loss-of-response to first-line biological therapies are more common in patients with Ulcerative Colitis than Crohn’s Disease – preliminary results from the Danish IBD Biobank ProjectECCO'22Year: 2022
Authors: Zhao, M.(1);Larsen, L.(2);Dige, A.(3);Hvas, C.L.(3);Poulsen, A.(4);Christiansen, D.(4);Attauabi, M.(1,5);Lo, B.(1);Wewer, M.(1,6);Ovesen, P.D.(6);Petersen, A.M.(1,7);Bendtsen, F.(1);Seidelin, J.B.(5);Burisch, J.(1,4);
(1)Hvidovre University Hospital, Gastro Unit- Medical Division, Hvidovre, Denmark;(2)Aalborg University Hospital, Dept. of Gastroenterology and Hepatology, Aalborg, Denmark;(3)Aarhus University Hospital, Dept. of Hepatology and Gastroenterology, Aarhus, Denmark;(4)Bispebjerg Hospital, Digestive Disease Centre, Copenhagen, Denmark;(5)Herlev University Hospital, The Gastro Unit- Medical Division, Hvidovre, Denmark;(6)University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark;(7)Hvidovre University Hospital, Dept. of Clinical Microbiology, Hvidovre, Denmark;
P406: Disease clearance in patients with ulcerative colitis treated with aminosalicylatesECCO'22Year: 2022
Authors: Nascimento, C.(1);Revés, J.(1);Roque Ramos, L.(1);Carolina, P.(1);Fidalgo, C.(1);Glória, L.(1);Torres, J.(1);
(1)Hospital Beatriz Ângelo, Gastrenterology, Loures, Portugal;
P407: A Phase IB/IIA study of remestemcel-L, an allogeneic bone marrow derived mesenchymal stem cell product, for the treatment of medically refractory ulcerative colitis: An interim analysisECCO'22Year: 2022
Authors: Lightner, A.(1);Dadgar, N.(2);Fulmer, C.(3);Ream, J.(4);Nachand, D.(4);Steele, S.(2);
(1)Cleveland Clinic, Department of Colorectal Surgery, Cleveland, United States;(2)Cleveland Clinic, Colorectal Surgery, Cleveland, United States;(3)Cleveland Clinic, Pathology, Cleveland, United States;(4)Cleveland Clinic, Radiology, Cleveland, United States;
P408: Faecal infliximab and disease activity in Acute Severe Ulcerative ColitisECCO'22Year: 2022
Authors: Shields, S.(1);Dunlop, A.(2);Gerasimidis, K.(3);Nichols, B.(3);Galloway, P.(2);Macdonald, J.(1);Hansen, R.(4);Seenan, J.P.(1);
(1)Queen Elizabeth University Hospital, Gastroenterology, Glasgow, United Kingdom;(2)Queen Elizabeth University Hospital, Biochemistry, Glasgow, United Kingdom;(3)University of Glasgow, School of Medicine- Dentistry & Nursing, Glasgow, United Kingdom;(4)Royal Hospital for Children, Gastroenterology, Glasgow, United Kingdom;
P409: FMT induced increase in gut microbial diversity and Clostridia is associated with clinical response in patients with ulcerative colitis – results from STOP Colitis trialECCO'22Year: 2022
Authors: Quraishi, M.N.(1);Quince, C.(2);Hewitt, C.(3);Beggs, A.(4);Gerasimidis , K.(5);Sharma, N.(1);Hawkey, P.(6);Oo, Y.(7);Ives, N.(3);Manzoor, S.(8);Loman, N.(6);Hansen, R.(9);Hart, A.(10);Gaya, D.(11);Iqbal, T.(1);
(1)University Hospitals Birmingham NHS Foundation Trust, Department of Gastroenterology, Birmingham, United Kingdom;(2)Earlham Institute-, Norwich Research Park, Norwich, United Kingdom;(3)Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom;(4)Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom;(5)Human Nutrition, University of Glasgow, Glasgow, United Kingdom;(6)Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom;(7)Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom;(8)University of Birmingham Microbiome Treatment Centre, University of Birmingham, Birmingham, United Kingdom;(9)Department of Paediatric Gastroenterology, Royal Hospital for Children Glasgow, Glasgow, United Kingdom;(10)Department of Gastroenterology, St Marks Hospital, London, United Kingdom;(11)Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom;
P410: safety of biological drugs for inflammatory bowel disease in elderly patientsECCO'22Year: 2022
Authors: Suarez Ferrer, C.J.(1);Mesonero, F.(2);Caballol, B.(3);Ballester, M.P.(4);Baston Rey, I.(5);Castaño Garcia, A.(6);Miranda Bautista, J.(7);Saiz Chumillas, R.(8);Benitez , J.M.(9);Sanchez Delgado, L.(10);Lopez-Garcia, A.(11);Rubin de Celix, C.(12);Lopez Sanroma, A.(2);Martin-Arranz, M.D.(13);Fernández-Clotet , A.(3);Merino Murgui , V.(14);Calviño Suárez , C.(15);Florez, P.(16);Lobato matilla, M.E.(7);Sicilia, B.(17);Soto Escribano, P.(18);Maroto Martin , C.(10);Alonso Abreu, I.(19);Melcarne, L.(20);Plaza Santos, R.(21);Marques Cami, M.(22);Caballero Mateos , A.(23);Gómez Díez , C.(24);Calafat, M.(25);Alonso Galan, H.(26);Vega Villaamil , P.(27);Castro Senosiain , B.(28);Guerro Moya , A.(29);Rodriguez Diaz , C.Y.(30);Spicakova, K.(31);Manceñido Marcos, N.(32);Molina, G.(33);De Castro, L.(34);Mañosa Ciria , M.(25);Barreiro-De Acosta , M.(15);
(1)Hospital Universitario La Paz, Gastroenterology Department. School of Medicine. Universidad Autónoma de Madrid. Hospital La Paz Institute forHealth Research- La Paz Hospital- Madrid, Madrid, Spain;(2)Hospital Universitario Ramon y Cajal, Gastroenterology, Madrid, Spain;(3)Hospital Clinic Barcelona, Gastroenterology, Barcelona, Spain;(4)Hospital Clinico de valencia, Gastroenterology, Valencia, Spain;(5)Hospital universitario Clinico de Santiago, Gastroenterology, Santiago de Compostela, Spain;(6)Hospital Universitario Central Asturias, Gastroenterology, Oviedo, Spain;(7)Hospital universitario Gregorio Marañon, Gastroenterology, Madrid, Spain;(8)Hospital Universitario Burgos, Gastroenterology, Burgos, Spain;(9)Hospital Reina Sofia, gastroenterology, Cordoba, Spain;(10)Hospital Universitario de Valladolid, Gastroenterology, Valladolid, Spain;(11)Hospital del Mar, gastroenterology, Barcelona, Spain;(12)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IISIP., Gastroenterology, Madrid, Spain;(13)Gastroenterology Department. School of Medicine. Universidad Autónoma de Madrid. Hospital La Paz Institute forHealth Research- La Paz Hospital, Gastroenterology, Madrid, Spain;(14)Hospital Clinico of Valencia, gastroenterology, Valencia, Spain;(15)Hospital Universitario Clínico de Santiago, Gastroenterology, Santiago de Compostela, Spain;(16)Hospital Universitario Central de Asturias, gastroenterology, Oviedo, Spain;(17)Burgos University Hospital, gastroenterology, Burgos, Spain;(18)Hospital Universitario Reina Sofia, gastroenterology, Cordoba, Spain;(19)Hospital Universitario de Canarias, Gastroenterology, Tenerife, Spain;(20)Hospital Universitari Parc Taulli- Sabadel, Gastroenterology, Barcelona, Spain;(21)Hospital Infanta Leonor Vallecas, Gastroenterology, Madrid, Spain;(22)Hospital Arnau de Vilanova, Gastroenterology, Lleida, Spain;(23)Hospital Clinico San Cecilio, gastroenterology, Granada, Spain;(24)Hospital Universitario Cabueñes, gastroenterology, Gijon, Spain;(25)Hospital Germans Trias i Pujol, gastroenterology, Badalona, Spain;(26)Hospital Universitario Donostia, gastroenterology, San Sebastian, Spain;(27)Complexo Hospitalario Universitario de Ourense, gastroenterology, Orense, Spain;(28)Hospital Universitario Marqués de Valdecilla. IDIVAL, gastroenterology, Santander, Spain;(29)Complexo Hospitalario Universitario A Coruña, gastroenterology, A Coruña, Spain;(30)Hospital Universitario Nuestra Señora de la Candelaria, gastroenterology, Tenerife, Spain;(31)Hospital Universitario de Alava, gastroenterology, Vitoria, Spain;(32)Hospital Infanta Sofia, Gastroenterology, Madrid, Spain;(33)Hospital Universitario de Ferrol, Gastroenterology, Ferrol, Spain;(34)Hospital Universitario Álvaro Cunqueiro, gastroenterology, Vigo, Spain;on belhaf of young group of GETECCU
P411: Stable pharmacokinetics and biochemical markers of inflammatory bowel disease activity: Results from a real-world adalimumab biosimilar switching programECCO'22Year: 2022
Authors: Moore, A.C.(1);Russell, D.(1);Dart, R.(1,2);Dias, S.(1);Ghuman, S.(1);Petri, B.(1);Sharma, E.(1);Ray, S.(1);Anderson, S.(1);Mawdsley, J.(1);Irving, P.M.(1);Samaan, M.A.(1);
(1)IBD Centre- St Thomas’ Hospital- NHS Foundation Trust- Westminster Bridge Road- Guy’s and St Thomas’- London- SE1 7EH- UK, Gastroenterology, London, United Kingdom;(2)Peter Gorer Dept of Immunobiology- DIIID- King’s College London- 2nd Floor Borough Wing- Guy’s Hospital- Great Maze Pond- London- SE1 9RT, Immunobiology, London, United Kingdom;
P412: Drug persistence and endoscopic, histologic and biochemical remission rates among patients following ileal pouch-anal anastomosis treated with biologic therapy: Results from a prospective patient cohort.ECCO'22Year: 2022
Authors: Ollech, J.(1);Yanai, H.(1);Avni-Biron, I.(1);Snir, Y.(1);Banai, H.(1);Broitman, Y.(1);Goren, I.(1);Wasserberg, N.(2);White, I.(2);Dotan, I.(1);
(1)Rabin Medical Center- Petah-Tikva- Israel- Sackler Faculty of Medicine- Tel Aviv University- Tel Aviv- Israel, Gastroenterology, Petach Tikva, Israel;(2)Rabin Medical Center- Petah-Tikva- Israel- Sackler Faculty of Medicine- Tel Aviv University- Tel Aviv- Israel, Surgery, Petach Tikva, Israel;
P413: Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b2 vaccines in the immunosuppressed (RESCUE)ECCO'22Year: 2022
Authors: Tran, A.P.(1,2);Tassone, D.(3,4);Nossent, J.C.(2,5);Ding, N.S.(3,4);
(1)St John of God Hospital, Wexford Medical Centre, Murdoch, Australia;(2)The University of Western Australia, School of Medicine and Pharmacology, Perth, Australia;(3)St Vincent's Hospital Melbourne, Gastroenterology, Fitzroy, Australia;(4)The University of Melbourne, Faculty of Medicine- Dentistry and Health Sciences, Parkville, Australia;(5)Sir Charles Gairdner Hospital, Department of Rheumatology, Perth, Australia;
P414: Stoma in patiens with IBD: friend or foe? -\tEffect of stoma on course of disease, psychological well-being and working capacityECCO'22Year: 2022
Authors: Bianchi, R.(1);Von Känel, R.(2);Roth, R.(3);Schreiner, P.(1);Rossel, J.B.(4);Barry, M.P.(4);Dora, B.(1);Kloth, P.(1);Juillerat, P.(5);Greuter, T.(6);Misselwitz, B.(5);Schoepfer, A.(6);Scharl, M.(1);Rogler, G.(1);Biedermann, L.(1);
(1)University Hospital Zurich and University of Zurich, Department of Gastroenterology and Hepatology, Zuerich, Switzerland;(2)University Hospital Zurich and University of Zurich, Department of Cunsultation Psychiatry and Psychosomatics, Zurich, Switzerland;(3)Spital Limmattal, Department of Internal Medicine, Schlieren, Switzerland;(4)Universiyt of Lausanne, Center for Primary Care and Public Health Unisanté, Lausanne, Switzerland;(5)Department of Visceral Surgery and Medicine, Department of Visceral Surgery and Medicine, Bern, Switzerland;(6)CHUV, Department of Gastroenterology and hepatology, Lausanne, Switzerland;
P415: Improving food‐related quality of life in Inflammatory Bowel Disease with a novel web-based intervention: a randomised controlled feasibility trialECCO'22Year: 2022
Authors: Cox, S.(1);Wall, C.(2);Clarke, H.(1);Drysdale, C.(1);Czuber-Dochan, W.(3);Lomer, M.(1);Lindsay, J.(4);Whelan, K.(1);
(1)King's College London, Department of Nutritional Sciences- Faculty of Life Sciences and Medicine, London, United Kingdom;(2)University of Otago Christchurch, Department of Medicine, Christchurch, New Zealand;(3)King's College London, Florence Nightingale Faculty of Nursing- Midwifery and Palliative Care, London, United Kingdom;(4)Barts Health NHS Trust, Department of Gastroenterology, London, United Kingdom;
P416: Addition of oral antibiotics to mechanical bowel preparation significantly improves anastomotic healing after ileocolic resection for Crohn’s diseaseECCO'22Year: 2022
Authors: Poredska, K.(1);Kunovský, L.(2);Marek, F.(2);Kala, Z.(2);Ivanecká, D.(2);Iesalnieks, I.(3);
(1)University Hospital Brno, Department of Gastroenterology and Internal Medicine, Masaryk University, Faculty of Medicine, Brno, Czech Republic;(2)University Hospital Brno, Department of Surgery, Masaryk University, Faculty of Medicine, Brno, Czech Republic;(3)Evangelisches Krankenhaus Kalk, Department of Surgery, Cologne, Germany;
P418: Development and validation of a digital health platform (IBD NutriCare) for telenutrition in patients with Inflammatory bowel diseaseECCO'22Year: 2022
Authors: Gupta, A.(1);Singh, N.(1);Madan, D.(1);Farooqui, M.(1);Singh, N.(1);Singh, M.(1);Virmani, S.(1);Verma, M.(1);Bajaj, A.(1);Markandey, M.(1);kante, B.(1);Vuyyuru, S.K.(1);Kumar, P.(1);Sahu, P.(1);Makharia, G.(1);Kedia, S.(1);Ahuja, V.(1);
(1)All India Institute of Medical Science, Department of Gastroenterology and Human Nutrition Unit, New Delhi, India;
